细胞因子靶点

经还原条件SDS-PAGE验证，Human IL-2RB&IL-2RG Heterodimer Protein, Fc Tag&Fc Tag (MALS verified) (Cat. No. ILG-H5254)纯度高于 95%；经 SEC-MALS 验证，纯度高于90%，分子量为140-160 kDa。

经还原条件SDS-PAGE验证，Biotinylated Human TGFBR2, Fc,Avitag (Cat. No. TG2-H82F6)纯度高于95%；经SEC-MALS验证，纯度高于90%，分子量为110-125 kDa。

经还原条件SDS-PAGE验证，Biotinylated Human TNF-alpha, His,Avitag (active trimer) (MALS verified) (Cat. No. TNA-H82E3)纯度高于95%；经SEC-MALS 验证，纯度高于90%，分子量为55-70 kDa。

经还原及非还原条件SDS-PAGE验证，Human GDF-15, Fc Tag (Cat. No. GD5-H5269)纯度高于95%；经SEC-MALS 验证，纯度高于90%，分子量为74-100 kDa。

经ELISA验证，固定的Human TGFBR2, Fc Tag (Cat. No. TG2-H5252) 可特异性结合Biotinylated Human TGF-Beta 1, Avitag (Cat. No. TG1-H8217) ，线性区间为0.1-3 ng/mL (QC tested)。

经ELISA验证，固定的Human M-CSF R, Fc Tag (Cat. No. CSR-H5258) 可特异性结合Biotinylated Human M-CSF, His,Avitag (Cat. No. MCF-H82E6)，线性区间为0.1-2 ng/mL (QC tested)。

经ELISA验证，固定的Human 4-1BB, Fc Tag (Cat. No. 41B-H5258) 可特异性结合Biotinylated Human 4-1BB Ligand, Fc, Avitag (Cat. No. 41L-H82F9)，线性区间为0.4-13 ng/mL (QC tested)。

经ELISA验证，固定的Cetuximab可特异性结合Human EGF R, His Tag (Cat. No. EGR-H5222)，线性区间为0.006-0.025 μg/mL (QC tested)。

经ELISA验证，固定的补体C5, His Tag (Cat. No. CO5-H52Ha)可特异性结合Anti-C5a (Human IgG1) 抗体，线性区间为0.2-3 ng/mL (QC tested)。

经SPR验证，通过anti-human IgG Fc抗体捕获在CM5芯片上的Erbitux (Cetuximab) 可特异性结合Human EGF R, His Tag (Cat. No. EGR-H5222)，亲和力常数为1.3 nM(Biacore T200)。

Human IL-2 R beta Protein, His Tag (Cat. No. CD2-H5221) captured on CM5 chip via anti-His antibody, can bind Human IL-15, premium grade (Cat. No. IL5-H4117) with an affinity constant of 21.7 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

经BLI验证，装载在Protein A 生物传感器上的Anti-IL23A & IL12B mAb (P40 domain) 可特异性结合Human IL-12B&IL-12A Heterodimer Protein, His Tag&Flag Tag (Cat. No. IL2-H4210) ，亲和力常数为1.07 nM (ForteBio Octet Red96e)。

经BLI验证，装载在Protein A 生物传感器上的Anti-IL23A & IL12B mAb (P40 domain) 可特异性结合Human IL-23A&IL-12B Heterodimer Protein, His Tag&Tag Free (Cat. No. ILB-H52W5) ，亲和力常数为0.588 nM(ForteBio Octet Red96e)。